Literature DB >> 23913915

Multiple imputation methods for handling missing data in cost-effectiveness analyses that use data from hierarchical studies: an application to cluster randomized trials.

Manuel Gomes1, Karla Díaz-Ordaz1, Richard Grieve1, Michael G Kenward2.   

Abstract

PURPOSE: Multiple imputation (MI) has been proposed for handling missing data in cost-effectiveness analyses (CEAs). In CEAs that use cluster randomized trials (CRTs), the imputation model, like the analysis model, should recognize the hierarchical structure of the data. This paper contrasts a multilevel MI approach that recognizes clustering, with single-level MI and complete case analysis (CCA) in CEAs that use CRTs.
METHODS: We consider a multilevel MI approach compatible with multilevel analytical models for CEAs that use CRTs. We took fully observed data from a CEA that evaluated an intervention to improve diagnosis of active labor in primiparous women using a CRT (2078 patients, 14 clusters). We generated scenarios with missing costs and outcomes that differed, for example, according to the proportion with missing data (10%-50%), the covariates that predicted missing data (individual, cluster-level), and the missingness mechanism: missing completely at random (MCAR), missing at random (MAR), or missing not at random (MNAR). We estimated incremental net benefits (INBs) for each approach and compared them with the estimates from the fully observed data, the "true" INBs.
RESULTS: When costs and outcomes were assumed to be MCAR, the INBs for each approach were similar to the true estimates. When data were MAR, the point estimates from the CCA differed from the true estimates. Multilevel MI provided point estimates and standard errors closer to the true values than did single-level MI across all settings, including those in which a high proportion of observations had cost and outcome data MAR and when data were MNAR.
CONCLUSIONS: Multilevel MI accommodates the multilevel structure of the data in CEAs that use cluster trials and provides accurate cost-effectiveness estimates across the range of circumstances considered.

Entities:  

Keywords:  cluster randomized trials; cost-effectiveness analysis; hierarchical data; missing data; multiple imputation

Mesh:

Year:  2013        PMID: 23913915     DOI: 10.1177/0272989X13492203

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  18 in total

1.  Long-term cost effectiveness of cardiac secondary prevention in primary care in the Republic of Ireland and Northern Ireland.

Authors:  Paddy Gillespie; Edel Murphy; Susan M Smith; Margaret E Cupples; Molly Byrne; Andrew W Murphy
Journal:  Eur J Health Econ       Date:  2016-03-09

2.  Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.

Authors:  Jan E Clarkson; Nigel B Pitts; Beatriz Goulao; Dwayne Boyers; Craig R Ramsay; Ruth Floate; Hazel J Braid; Patrick A Fee; Fiona S Ord; Helen V Worthington; Marjon van der Pol; Linda Young; Ruth Freeman; Jill Gouick; Gerald M Humphris; Fiona E Mitchell; Alison M McDonald; John Dt Norrie; Kirsty Sim; Gail Douglas; David Ricketts
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

3.  Design and sample characteristics of COordinated Oral health Promotion (CO-OP) Chicago: A cluster-randomized controlled trial.

Authors:  Molly A Martin; Lacey J Zimmerman; Genesis F Rosales; Helen H Lee; Nattanit Songthangtham; Oksana Pugach; Anna S Sandoval; David Avenetti; Gizelle Alvarez; Stuart A Gansky
Journal:  Contemp Clin Trials       Date:  2019-12-30       Impact factor: 2.226

4.  Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial.

Authors:  Paddy Gillespie; Eamon O'Shea; Mary Clare O'Hara; Sean F Dinneen
Journal:  Trials       Date:  2014-06-14       Impact factor: 2.279

5.  A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials.

Authors:  Rita Faria; Manuel Gomes; David Epstein; Ian R White
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

6.  Addressing Missing Data in Patient-Reported Outcome Measures (PROMS): Implications for the Use of PROMS for Comparing Provider Performance.

Authors:  Manuel Gomes; Nils Gutacker; Chris Bojke; Andrew Street
Journal:  Health Econ       Date:  2015-03-05       Impact factor: 3.046

7.  Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial.

Authors:  Zahidul Quayyum; Andrew Briggs; Jose Robles-Zurita; Keith Oldroyd; Uwe Zeymer; Steffen Desch; Suzanne de Waha; Holger Thiele
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

8.  Handling incomplete correlated continuous and binary outcomes in meta-analysis of individual participant data.

Authors:  Manuel Gomes; Laura Hatfield; Sharon-Lise Normand
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

9.  Multiple imputation methods for bivariate outcomes in cluster randomised trials.

Authors:  K DiazOrdaz; M G Kenward; M Gomes; R Grieve
Journal:  Stat Med       Date:  2016-03-14       Impact factor: 2.373

Review 10.  Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Authors:  Elena Olariu; Kevin K Cadwell; Elizabeth Hancock; David Trueman; Helene Chevrou-Severac
Journal:  Clinicoecon Outcomes Res       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.